+ Filter

Teplizumab

Anti-Teplizumab Products

Rabbit Anti-Teplizumab Antibody, XFD350 Conjugated (ABA-062WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, XFD405 Conjugated (ABA-063WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, FITC Conjugated (ABA-064WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, PE Conjugated (ABA-065WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, APC Conjugated (ABA-066WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, APC-Cy7 Conjugated (ABA-067WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody, Cy7 Conjugated (ABA-068WJ)
- Type: Rabbit IgG
- Application: FC
Compare

Rabbit Anti-Teplizumab Antibody (ABA-069WJ)
- Type: Rabbit IgG
- Application: FC, WB
Compare

View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Background

Teplizumab (also known as PRV-031; formerly also known as MGA031 and hOKT3γ1(Ala-Ala)) is a humanized anti-CD3 monoclonal antibody that is being evaluated for treatment and prevention of type 1 diabetes mellitus (T1DM) by the biopharmaceutical company Provention Bio. Teplizumab has also been evaluated for treatment of renal allograft rejection, for induction therapy in islet transplant recipients, and for psoriatic arthritis.